KADUWZJENYYSQJ-VEIFNGETSA-N
C42H45Cl2F3N6O6S2 — CID 159075180
Data last refreshed: (MolForge compound catalog, from PubChem)
About KADUWZJENYYSQJ-VEIFNGETSA-N
KADUWZJENYYSQJ-VEIFNGETSA-N (PubChem CID 159075180) has the molecular formula C42H45Cl2F3N6O6S2 and a molecular weight of 921.89 g/mol. Its IUPAC name is 2-(4-chlorophenyl)-N-ethyl-2-[4-(methanesulfonamido)indol-1-yl]butanamide;(2R)-2-(4-chlorophenyl)-2-[4-(methanesulfonamido)indol-1-yl]-N-(2,2,2-trifluoroethyl)butanamide.
Molecular Properties
| Compound Name | KADUWZJENYYSQJ-VEIFNGETSA-N |
|---|---|
| PubChem CID | 159075180 |
| Molecular Formula | C42H45Cl2F3N6O6S2 |
| Molecular Weight | 921.89 g/mol |
| Exact Mass | 920.22 |
| IUPAC Name | 2-(4-chlorophenyl)-N-ethyl-2-[4-(methanesulfonamido)indol-1-yl]butanamide;(2R)-2-(4-chlorophenyl)-2-[4-(methanesulfonamido)indol-1-yl]-N-(2,2,2-trifluoroethyl)butanamide |
| SMILES | CCNC(=O)C(CC)(c1ccc(Cl)cc1)n1ccc2c(NS(C)(=O)=O)cccc21.CC[C@](C(=O)NCC(F)(F)F)(c1ccc(Cl)cc1)n1ccc2c(NS(C)(=O)=O)cccc21 |
| InChI | InChI=1S/C21H21ClF3N3O3S.C21H24ClN3O3S/c1-3-20(14-7-9-15(22)10-8-14,19(29)26-13-21(23,24)25)28-12-11-16-17(27-32(2,30)31)5-4-6-18(16)28;1-4-21(20(26)23-5-2,15-9-11-16(22)12-10-15)25-14-13-17-18(24-29(3,27)28)7-6-8-19(17)25/h4-12,27H,3,13H2,1-2H3,(H,26,29);6-14,24H,4-5H2,1-3H3,(H,23,26)/t20-;/m1./s1 |
| InChIKey | KADUWZJENYYSQJ-VEIFNGETSA-N |
| XLogP | 8.45 |
| TPSA | 160.40 Ų |
| H-Bond Donors | 4 |
| H-Bond Acceptors | 8 |
| Rotatable Bonds | 14 |
| Heavy Atoms | 61 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 921.89 |
| LogP ≤ 5 | 8.45 |
| H-Bond Donors ≤ 5 | 4 |
| H-Bond Acceptors ≤ 10 | 8 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 159075180 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.